Search
×
FR

Placeholder headline

This is just a placeholder headline

ISO 10993-7:2026 Biological evaluation of medical devices — Part 7: Ethylene oxide sterilization residuals

$

422

BUY NOW

ISO 18990:2025

ISO 18990:2025 Measurement of radioactivity in urine-238Pu, 239Pu and 240Pu — Test method using alpha spectrometry or ICP-MS

CDN $337.00

This publication was last reviewed and confirmed in 2025.

Measurement of radioactivity in urine-238Pu, 239Pu and 240Pu — Test method using alpha spectrometry or ICP-MS

SKU: edec1a8c1727 Categories: ,

Description

This document specifies approaches for the determination of plutonium isotopes (238Pu, 239Pu and 240Pu) in urine using alpha spectrometry or inductively coupled plasma mass spectrometry (ICP-MS).

It is applicable to the measurement of plutonium isotopes at levels which are appropriate for

     workers handling plutonium in planned exposure situations, where detection limits are sufficiently low to be in accordance with dose limits, and

     workers, members of the public and emergency responders in emergency exposure situations, where required detection limits can be much higher, and results need to be reported in a short timescale.

This document does not provide information on when monitoring is carried out or the interpretation of the results in terms of dose or biological effects.

Edition

1

Published Date

2026-06-19

Status

PUBLISHED

Pages

37

Language Detail Icon

English

Format Secure Icon

Secure PDF

Abstract

This document specifies approaches for the determination of plutonium isotopes (238Pu, 239Pu and 240Pu) in urine using alpha spectrometry or inductively coupled plasma mass spectrometry (ICP-MS).

It is applicable to the measurement of plutonium isotopes at levels which are appropriate for

     workers handling plutonium in planned exposure situations, where detection limits are sufficiently low to be in accordance with dose limits, and

     workers, members of the public and emergency responders in emergency exposure situations, where required detection limits can be much higher, and results need to be reported in a short timescale.

This document does not provide information on when monitoring is carried out or the interpretation of the results in terms of dose or biological effects.

Previous Editions

Can’t find what you are looking for?

Please contact us at: